Latest filing published 29 Jun 2018 for MedReleaf Corp., €400k.
This profile gathers the share dealings of Jason Fleming in MedReleaf Corp. The record holds 4 filings, for trades running from 1 April 2018 to 25 June 2018.
The open-market record consists of 2 sales worth €429k, with no purchase. Besides market trades, the filings include 1 option exercise.
Most recently, on 29 June 2018, the filings show an open-market sale worth €400k in MedReleaf Corp. Filings reach the SEDI feed a median of 4 days after the trade. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations